Background: Bacillus Calmette-Guerin (BCG) bladder instillations have been long known to successfully treat non-muscle invasive bladder cancer. The objective of this report is to highlight the first case to our knowledge of Varicella Zoster virus (VZV) shingles reactivation to BCG.
Case presentation: An 80-year-old male with history of Parkinsonís disease and recurring high-grade T1 bladder cancer. Five days after first repeat BCG instillation, patient presented to the emergency room with a progressively worsening rash that started 1 day after treatment, characterized as VZV shingles reactivation. Intravenous acyclovir treatment produced rapid clinical improvement.
Conclusion: Reactivation of dormant VZV infection may be a reaction to BCG intravesical instillation. This is, to the authorsí knowledge, the first documented case of this complication. Although coincidence cannot be completely ruled out, the timing of this case and the context of immunosuppression-immunomodulation inherent to BCG therapy make causality plausible.
BCG, shingles, bladder cancer, adverse reaction, varicella zoster, case report
A sensitive electrochemiluminescence biosensor for assay of cancer biomarker (MMP-2) based on NGQDs-Ru@SiO2 luminophore.
Fan X, Wang S, Liu H, Li Z, Sun Q, Wang Y, Fan X
Talanta. 2022; 236(): 122830
Adverse consequences of emotional support seeking through social network sites in coping with stress from a global pandemic.
Islam AKMN, M√§ntym√§ki M, Laato S, Turel O
International journal of information management. 2022; 62(): 102431
Hypoxia and Proton microbeam: Role of Gap Junction Intercellular Communication in Inducing Bystander Responses on Human Lung Cancer Cells and Normal Cells.
Autsavapromporn N, Kobayashi A, Liu C, Jaikang C, Ahmad TAT, Oikawa M, Konishi T
Radiation research. 2022; ():
Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
Llop E, Peracaula R
Methods in molecular biology (Clifton, N.J.). 2022; 2370(): 301-313
3D and 4D Tumorigenesis Model for the Quantitative Analysis of Cancer Cell Behavior and Screening for Anticancer Drugs.
Wessels D, Lusche DF, Voss E, Soll DR
Methods in molecular biology (Clifton, N.J.). 2022; 2364(): 299-318